Stockscreener 앱 받기
0.423
2.76%
-0.012
전일 마감가:
$0.435
열려 있는:
$0.42
하루 거래량:
350.29K
Relative Volume:
0.17
시가총액:
$17.73M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.6714
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+13.28%
1개월 성능:
+20.86%
6개월 성능:
-21.67%
1년 성능:
-86.40%
1일 변동 폭
$0.4146
$0.4394
1주일 범위
$0.3525
$0.445
52주 변동 폭
$0.2179
$3.3654
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.4269 | 16.22M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
478.83 | 161.42B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
203.79 | 135.99B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
546.27 | 42.78B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
202.32 | 31.85B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.50 | 33.01B | 6.63B | 1.17B | 1.19B | 4.05 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest
What analysts say about ProPhase Labs Inc. stockOutstanding capital appreciation - jammulinksnews.com
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire
ProPhase Labs secures $3 million in convertible notes financing - Investing.com India
Prophase Labs Secures $3 Million in Private Financing - TipRanks
ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com
ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus
ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.81%
0.31%
자본화:
|
볼륨(24시간):